This stylish smart ring is like wearing a personal assistant on your finger
This stylish smart ring is like wearing a personal assistant on your finger
Biopolymers market will register an incremental spend of about USD 3,493 million, growing at a CAGR of 13.25% during the five-year forecast period.
The Vic Open, an Australian event that is part of both the LPGA Tour and the men's European Tour, was canceled for 2021 due to the coronavirus pandemic. The announcement regarding the scheduled February tournament was made Thursday (Australia time). The tournament is held at the 13th Beach Golf Links in Barwon Heads, Victoria, near Melbourne.
Game 1 of the World Series was all about Mookie Betts and his quest to give the Los Angeles Dodgers a title and fans across the country a free taco. Game 2 gave us a $27.50 hot dog that could feed the family, and a reminder that the Tampa Bay Rays may be even better than the sum of their bargain basement parts. Now Major League Baseball can only hope that fans are hungrier for more.
From pickled vine leaves to coffee and cheese, Saudi supermarkets are taking Turkish products off the shelves after calls for a boycott, as rivalry between Riyadh and Ankara heats up.
Those following along with boohoo group plc (LON:BOO) will no doubt be intrigued by the recent purchase of shares by...
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Bodycote plc...
Indian businesses are stocking up more ahead of this year's big festival season than at any time in the last five years, expecting people whose earnings were relatively unaffected by the pandemic to spend the money they saved during months of lockdowns. India's biggest shopping season is at the time of the festivals of Durga Puja and Diwali, which fall 20 days apart in October-November each year. Businesses and shopkeepers expect more purchases than usual this year, beginning with Durga Puja on Thursday, because the months of lockdowns have resulted in pent-up demand.
The televised meeting comes as Trump badly needs to alter the trajectory of the race. A record 42 million Americans have already cast ballots ahead of the debate in Nashville, Tennessee, meaning Trump's window to influence the outcome of the race may be closing. The contentious first debate between Biden and Trump was watched by at least 73 million viewers.
A secretive 2018 agreement between Beijing and the Vatican is on the brink of renewal, despite strident US condemnation and warnings from underground Chinese priests loyal to Rome that they have only become more marginalised since it was signed.
BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that it will receive a €2 million milestone payment under its collaboration with Daiichi Sankyo related to the initiation of a global Phase I clinical trial with an anti-glycoprotein A repetitions predominant (GARP) directed antibody.
BOSTON, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic™ platform, today announced the pricing of its public offering of 4,687,500 shares of its common stock at a public offering price of $40.00 per share. In addition, in lieu of common stock to certain investors, Replimune today announced the pricing of its public offering of pre-funded warrants to purchase 1,562,500 shares of its common stock at a purchase price of $39.9999 per pre-funded warrant, which equals the public offering price per share of the common stock less the $0.0001 per share exercise price of each pre-funded warrant. The aggregate gross proceeds from the offering are expected to be approximately $250 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by Replimune. All securities in the offering are being offered by Replimune. In addition, Replimune has granted the underwriters a 30-day option to purchase up to an additional 937,500 shares of its common stock from Replimune at the public offering price, less the underwriting discounts and commissions. The offering is expected to close on October 26, 2020, subject to the satisfaction of customary closing conditions. J.P. Morgan Securities LLC, SVB Leerink LLC and Barclays Capital Inc. are acting as joint book-running managers for the offering. Wedbush Securities Inc. is acting as lead manager for the offering and Roth Capital Partners, LLC is acting as co-manager for the offering.A preliminary prospectus supplement and a free writing prospectus relating to and describing the terms of the offering were filed with the Securities and Exchange Commission (the “SEC”) on October 20, 2020 and October 21, 2020, respectively. The final prospectus supplement relating to the offering will be filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained, when available, by visiting EDGAR on the SEC website at www.sec.gov or from: J.P. Morgan Securities LLC, Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204, or by e-mail at email@example.com; SVB Leerink LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, by telephone at (800) 808-7525, ext. 6132, or by e-mail at firstname.lastname@example.org or Barclays Capital Inc., Attention: Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone: 1-888-603-5847, or by e-mail at email@example.com. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC.The shares of common stock and the pre-funded warrants described above are being offered by Replimune pursuant to its shelf registration statement on Form S-3, including a base prospectus, that was previously filed by Replimune with the SEC on August 11, 2020 and declared effective by the SEC on August 26, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities, in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.About Replimune Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 to develop the next generation of oncolytic immuno-gene therapies for the treatment of cancer. Replimune is developing novel, proprietary therapeutics intended to improve the direct cancer-killing effects of selective virus replication and the potency of the immune response to the tumor antigens released. Replimune’s Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral-mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune-activating proteins to the tumor and draining lymph nodes.Forward-Looking Statements This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding our public offering, our goals to develop and commercialize our product candidates, the gross proceeds we expect to receive from our public offering, and other statements identified by words such as “could,” “expects,” “intends,” “may,” “plans,” “potential,” “should,” “will,” “would,” or similar expressions and the negatives of those terms. Forward-looking statements are not promises or guarantees of future performance, and are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in such forward-looking statements. These factors include risks related to market conditions, the completion of our public offering on the anticipated terms or at all, our limited operating history, our ability to generate positive clinical trial results for our product candidates, the costs of operating our in-house manufacturing facility, the timing and scope of regulatory approvals, changes in laws and regulations to which we are subject, competitive pressures, our ability to identify additional product candidates, political and global macro factors including the impact of the coronavirus as a global pandemic and related public health issues, and other risks as may be detailed from time to time in our Annual Reports on Form 10-K and Quarterly Reports on Form 10-Q and other reports we file with the SEC, and in the preliminary prospectus supplement, the free writing prospectus, the final prospectus supplement, once filed with the SEC, and the accompanying prospectus. Our actual results could differ materially from the results described in or implied by such forward-looking statements. Forward-looking statements speak only as of the date hereof, and, except as required by law, we undertake no obligation to update or revise these forward-looking statements.Investor Inquiries Chris Brinzey Westwicke, an ICR Company 339.970.2843 firstname.lastname@example.org
(Bloomberg) -- Tata Consultancy Services Ltd., Asia’s biggest software exporter by market value, is in advanced talks to acquire a technology services unit of Deutsche Bank AG, people with knowledge of the matter said.The discussions about the Bonn-based Postbank Systems AG are expected to result in a deal with the Indian company by the end of the year, the people said, asking not to be identified discussing the private information.The pandemic is accelerating moves by global banks and financial services firms to shed their captive technology centers. Tata Consultancy’s potential takeover of Postbank’s 1,400 employees in the South Asian nation will help Deutsche Bank Chief Executive Officer Christian Sewing get closer to his job-cuts target.Negotiations are ongoing and could still be delayed or fall apart, the people said. A Deutsche Bank spokeswoman declined to comment, while a representative for Tata Consultancy also didn’t comment.Tata Consultancy, which has more than 450,000 employees across the world, in 2008 paid $505 million to acquire Citigroup Inc.’s back-office unit in what was then its biggest acquisition. Financial details of the proposed transaction with Deutsche Bank aren’t known.Shares of the unit of Tata Sons Pvt., India’s biggest conglomerate, were little changed at 2,673.8 rupees at 9:35 a.m. in Mumbai.Deutsche Bank’s Sewing last year unveiled a restructuring plan centered on cutting 18,000 jobs, with about half of those expected in Germany, Bloomberg News has reported.PB Systems generated 533 million euros ($632 million) in revenue in 2015, according to its latest available annual report. The unit provides IT services to Deutsche Bank’s formerly separate retail unit Postbank.Deutsche Bank is currently merging Postbank’s IT with its own, which is expected to render the services provided by PB Systems obsolete by the end of next year. The plan, known internally as Project Unity, is expected to contribute the lion’s share to Sewing’s goal of cutting 1 billion euros of expenses in the German retail operations.Deutsche Bank also recently unveiled a plan to move much of its IT into the cloud as part of a deal with Alphabet Inc.’s Google. The bank said in July it expects to sign the contract with Google “within the next few months.”(Updates with Tata Consultancy in talks for the asset throughout the story)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.
Luis Arce, the quiet economist who will take over as Bolivia's president next month after a landslide election win, knew where he stood in the political spectrum as a young teenager in La Paz, when he picked up the writings of German philosopher Karl Marx. Arce steered the Andean country's economy for over a decade under former leader Evo Morales, an ebullient leftist who resigned last year after an election dogged by disputed claims of fraud sparked widespread protests. Arce was often seen as a moderating influence to more radical elements in Morales' Movement towards Socialism (MAS) party.
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030" report has been added to ResearchAndMarkets.com's offering. The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030.The market is driven by certain factors, which include the increasing global geriatric population, increasing incidence of chronic diseases including neurodegenerative disorder, and the presence of high unmet clinical needs regarding treatment for immune disorders, and significant external funding for executing R&D exercises.The market is favored by the development of neurodegenerative disorder therapeutics for several clinical areas such as Multiple sclerosis, Parkinson's disease, Alzheimer's disease, Spinal Muscular Atrophy, Huntington disease, and other neurodegenerative disorders. The increase in the geriatric population and incurable neurodegenerative disorders across the globe are expected to translate into significantly higher demand for neurodegenerative disorder therapeutics market.Furthermore, the companies are investing huge amounts in research and development of neurodegenerative disorder therapeutics either as a monotherapy or as combination therapy. The clinical trial landscape of different neurodegenerative disorders has been on the rise in recent years, and this will fuel the neurodegenerative disorder therapeutics market in the future.Within the research report, the market is segmented based on indication, drug class, route of administration, and region. Each of these segments covers the market's snapshot over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.Competitive LandscapeThe exponential rise in the application of precision medicine on a global level has created a buzz among companies to invest in the development of novel neurodegenerative disorder therapeutics. Due to the diverse product portfolio and intense market penetration, Biogen Inc. has been a pioneer in this field and has been a significant competitor in this market.Several other companies such as Novartis AG, F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company, among others, have launched therapies for neurodegenerative disorder, such as Mayzent (siponimod), Ocrevus (ocrelizumab), and Zeposia (ozanimod) respectively, to compete with Biogen Inc.'s Tecfidera (dimethyl fumarate) therapy market dominance.Based on region, North America holds the largest share of neurodegenerative disorder therapeutics market due to improved healthcare infrastructure, rise in per capita income, and availability of state-of-the-art research laboratories and institutions in the region. Apart from this, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period.Market Dynamics Growth Drivers * Rising Global Prevalence of Neurodegenerative Disorders * The Increase in Number of Geriatric Populations * Increasing Research Funding in Neurodegenerative Disorders * Rising Awareness about Neurodegenerative DisordersMarket Challenges * High Failure Rate of Neurodegenerative Drugs in Clinical Trials * Lack of Effective Drugs and TherapiesMarket Opportunities * Development of Novel therapies for Neurodegenerative Disorders through Gene and Cell Therapies * Massive Scope for Adoption of Neurodegenerative Disorders Therapeutics in Emerging NationsCompanies Mentioned * AbbVie Inc. * Bayer AG * Biogen Inc. * Bristol-Myers Squibb Company * C. H. Boehringer Sohn AG & Co. KG * Eisai Inc. * F. Hoffmann-La Roche Ltd. * GlaxoSmithKline plc * H. Lundbeck A/S * Merck KGaA * Novartis AG * Pfizer Inc. * Sanofi S.A. * Teva Pharmaceutical Industries Ltd. * UCB Pharma SAFor more information about this report visit https://www.researchandmarkets.com/r/ecc27bResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Amazon.com Inc said on Thursday it has invested $100 million in opening new warehouses in Mexico, including its first shipping centers outside the populous capital area, in a bid to offer faster deliveries. The new sites include two so-called fulfillment centers - one near the northern city of Monterrey and another near the central city of Guadalajara - as well as a support building in the State of Mexico, just outside Mexico City. Amazon also opened 12 delivery stations, bringing its total to 27 across the country, it said.
Users of the Zoe app received an email promoting face coverings designed by Samantha Cameron.
A deposition British socialite Ghislaine Maxwell gave in 2016 related to her dealings with the late financier Jeffrey Epstein is expected to be made public on Thursday, a document Maxwell had fought hard to keep under wraps. Maxwell, 58, has pleaded not guilty to helping Epstein recruit and groom underage girls as young as 14 to engage in illegal sexual acts in the mid-1990s, and not guilty to perjury for having denied involvement in any such scheme when she gave her deposition under oath. The April 2016 deposition came from a now-settled civil defamation lawsuit against Maxwell by Virginia Giuffre, who has said Epstein kept her as a "sex slave" with Maxwell's assistance.
Halper Sadeh LLP, a global investor rights law firm, is investigating:
The Guantanamo detainees were promised they were being sent to a Muslim country for rehabilitation that would help integrate them into society, opening the way to jobs, money, and marriage, according to their lawyers and families. Instead, the detainees -- 18 Yemenis and one Russian, swept up from Afghanistan and Pakistan after the Sept. 11 attacks -- have languished in custody in the United Arab Emirates for as long as five years, their families and lawyers tell The Associated Press. In short, sporadic phone calls from undisclosed locations in the UAE — including a notorious prison rife with torture — several whispered to their families that as bad as life in Guantanamo was, they wish they could return there.
Ireland became the first European country to enter a second national lockdown and Germany's daily cases leapt to a record high as the second wave of coronavirus spread gloom across the continent on Thursday.